跳至主要内容
临床试验/NCT05041816
NCT05041816撤回不适用

Peripheral Nerve Responses to Focal Vibration and Implications in Pain and Mobility for Patients With Diabetic Peripheral Neuropathy

University of Oklahoma2 个研究点 分布在 1 个国家开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Changes in CMAP

研究概览

简要总结

The purpose of this study is to characterize the changes in peripheral nerve functions (sensory and motor) in patients with diabetic peripheral neuropathy, and examine the relations between the changes in nerve functions and changes in pain and mobility using focal vibration.

详细描述

Peripheral nerve impairments are highly prevalent in patients with diabetic peripheral neuropathy (DPN) and are associated with pain and poor mobility. While peripheral sensorimotor nerve function is implicated in neuropathy, the mechanism associated with both pain and mobility is not well understood. Even less understood is the interplay between, and responses to, sensory and motor fibers of the affected peripheral nerve. In our previous study, focal vibration (FV) was effective in reducing pain and improving mobility for only a subgroup of participants with DPN. Because FV stimulates both motor and sensory peripheral nerve fibers, when combined with nerve conduction testing, it offers a unique opportunity to study both the sensory and motor peripheral nerve performance and their contribution to pain and mobility in patients with DPN. We are proposing a single group, repeated measured study to: characterize the changes in sensory and motor peripheral nerve functions; examine the association(s) between these changes and changes in pain and mobility, using FV. If successful, this study will provide us with a better understanding of the role played by sensory and motor nerve impairments in pain and mobility for DPN, and support larger clinical studies to optimize nerve function performance and the FV parameters. We will also explore how changes in the peripheral nerve function associate with severity of DPN.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of diabetes for at least one year;
  • Diabetic peripheral neuropathy as defined by failure to sense the 5.07 (10g) monofilament test in one or more of the six sites tested;
  • Age 45-80 years old;
  • Able to ambulate independently without assistive devices (e.g., walker or crutches) for 30 feet;
  • No evidence of neurological (other than peripheral neuropathy) or orthopedic conditions;
  • Able to understand English instructions;
  • Have normal or corrected vision.

排除标准

  • With other non-diabetic causes of neuropathy by history;
  • Symptomatic peripheral vascular disease, joint pain, swelling and/or limited range of motion in the lower extremities that interfere with walking;
  • Other systemic or local diseases that could interfere with walking assessment
  • Amputation in the lower extremities;
  • Clinically diagnosed with dementia greater than mild (screened using Montreal Cognitive Assessment (MOCA) <24)

结局指标

主要结局

Changes in CMAP

时间窗: Change from Baseline CMAP measures every 2 weeks for up to 6 weeks

The peroneal compound muscle action potential (CMAP)

Changes in TUG

时间窗: Change from Baseline TUG scores every 2 weeks for up to 6 weeks

Timed Up and Go (TUG) test

Changes in NTSS-6

时间窗: Change from Baseline NTSS-6 scores every 2 weeks for up to 6 weeks

The Neuropathy Total Symptom Score - 6-items (NTSS-6), which quantifies frequency and intensity of aching, burning, prickling and lancinating pain, numbness, and allodynia in patients' feet and legs.

Changes in NSS

时间窗: Change from Baseline NSS scores every 2 weeks for up to 6 weeks

The Neuropathy Symptom Score (NSS), which quantifies symptoms of motor, sensory, and autonomic deficits.

Changes in BPI-DPN

时间窗: Change from Baseline BPI-DPN scores every 2 weeks for up to 6 weeks

The Brief Pain Inventory Short Form for Diabetic Peripheral Neuropathy

Changes in NIS

时间窗: Change from Baseline NIS scores every 2 weeks for up to 6 weeks

The Neurologic Impairment Score (NIS), composed of a sensory sub-score (which evaluates sensory perceptions to touch, prickling pain, vibration, joint position, and 1- and 10-g monofilaments in the upper and lower extremities) and a motor sub-score (which evaluates cranial nerves, muscle strength, muscle wasting, and deep tendon reflexes in the upper and lower extremities).

Changes in NCV

时间窗: Change from Baseline NCV measures every 2 weeks for up to 6 weeks

The peroneal motor nerve conduction velocity

Changes in SNAP

时间窗: Change from Baseline SNAP measures every 2 weeks for up to 6 weeks

The digital sensory nerve action potentials

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验